Results 71 to 80 of about 273 (147)

Antipsychotics induced hyperprolactinaemia and osteoporosis

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Antipsychotic drugs block dopamine D2 receptors and thus remove the inhibitory influence on prolactin secretion. Hyperprolactinemia is a common side effect of treatment with antipsychotics.
Semiha Tufan Temiz, Atila Erol
doaj  

Clozapine in tardive dyskinesia: Four treatment resistant patients with mood disorder

open access: yes, 2000
Geç diskinezi antipsikotik ilaç kullanımının görece geç dönemlerinde ortaya çıkan bir hareket bozukluğudur, ileri yaş, kadın cinsiyeti ve duygudurum bozukluğu tanısının geç diskinezi riskini artırdığı belirtilmektedir.
M. Ayşın Noyan   +2 more
core  

Atypical antipsychotics in treatment of bipolar disorder in special populations

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Atypical antipsychotics have increased usage during the last decades. While they were used in treatment resistant schizophrenia patients at the beginning, they have gained widespread use in treatment of various psychiatric disorders including acute ...
Servet Ebrinç   +2 more
doaj  

THE EFFECTS OF DIFFERENT CALCIUM CHANNEL BLOCKERS ON PHENYLETHYLAMINE (PEA)-INDUCED SCHIZOPHRENIA MODEL IN THE RATS

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: Calcium channel blockers have been used commonly in the treatment of cardiovascular diseases and have also been the subject of speculation in the treatment of various CNS disorders, including migraine, mania, depression, Tourette’s disorder ...
Günnur Özbakış Dengiz   +1 more
doaj  

Clozapine treatment in bipolar and schizoaffective disorders: A retrospective study

open access: yes, 2002
Amaç: Bu çalışmanın amacı, klozapin kullanan bipolar bozukluk ve Şizoaffektif bozukluk tanısı konan hastaların sosyodemografik ve klinik özellikleriyle ilaca yanıtlarını araştırmaktır.
Simavi Vahip   +2 more
core  

One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study. [PDF]

open access: yesJ Clin Psychopharmacol, 2020
Drosos P   +8 more
europepmc   +1 more source

Severe extrapyramidal symptoms due to valproate plus low dose olanzapine: A case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
In many studies comparing extrapyramidal system (EPS) side effects due to olanzapine and other atypical antipsychotics, it has been shown that olanzapine induces these effects less than risperidone and comparable to clozapine.
Demet Dankı   +2 more
doaj  

Evidence-based guidelines for the antipsychotic drugs: Schizophrenia

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Antipsychotic medications, as the standard pharmacologic treatment of schizophrenia, are used to decrease symptoms and to increase functioning. The currently available antipsychotics are all significantly efficacious for positive symptoms.
Özcan Uzun
doaj  

Yeni antipsikotikler ve haloperidolün prolaktin üzerindeki etkilerinin karşılaştırılması [PDF]

open access: yes, 2008
Amaç: Bu natüralistik izleme çalışması ile, şizofreni veya sanrılı bozukluk tanılı hastalarda haloperidol ve yeni antipsikotiklerin prolaktin düzeyi üzerindeki etkilerinin karşılaştırılması amaçlanmıştır.
Kurt, Erhan   +2 more
core  

Predictors of antipsychotic monotherapy treatment in patients with schizophrenia: Results from a naturalistic observational study

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objectives: To identify baseline factors associated with initiating antipsychotic monotherapy in the treatment of outpatients with schizophrenia, who were initiated at baseline on olanzapine, risperidone, quetiapine, amisulpride, clozapine, oral or ...
Diego Novic   +6 more
doaj  

Home - About - Disclaimer - Privacy